Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases

• Alex Fonollosa,
• Alex Fonollosa,
• Ester Carreño,
• Ester Carreño,
• Antonio Vitale,
• Ankur K. Jindal,
• Athimalaipet V. Ramanan,
• Laura Pelegrín,
• Borja Santos-Zorrozua,
• Verónica Gómez-Caverzaschi,
• Luca Cantarini,
• Claudia Fabiani,
• José Hernández-Rodríguez

Affiliations

Alex Fonollosa

Department of Ophthalmology, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Barakaldo, Spain

Alex Fonollosa

Department of Retina, Instituto Oftalmológico Bilbao, Bilbao, Spain

Ester Carreño

Department of Ophthalmology, Rey Juan Carlos University Hospital, Madrid, Spain

Ester Carreño

Department of Ophthalmology, Fundación Jiménez Díaz University Hospital, Madrid, Spain

Antonio Vitale

Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Siena, Italy

Ankur K. Jindal

Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

Athimalaipet V. Ramanan

Department of Paediatric Rheumatology, Bristol Royal Hospital for Children and Translational Health Sciences, University of Bristol, Bristol, United Kingdom

Laura Pelegrín

Department of Ophthalmology, Institut Clínic d’Oftalmologia (ICOF), Hospital Clinic de Barcelona, University of Barcelona, Institut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Borja Santos-Zorrozua

Department of Biostatistics, Biocruces Bizkaia Health Research Institute, Bilbao, Spain

Verónica Gómez-Caverzaschi

0Autoinflammatory Diseases Clinical Unit, Department of Autoimmune Diseases, Hospital Clínic de Barcelona, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d’Unitats d’Expertesa Clínica (XUEC) for Autoinflammatory Diseases, Barcelona, Spain

Luca Cantarini

Research Center of Systemic Autoinflammatory Diseases and Behçet’s Disease Clinic, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Siena, Italy

Claudia Fabiani

1Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Siena, Italy

José Hernández-Rodríguez

0Autoinflammatory Diseases Clinical Unit, Department of Autoimmune Diseases, Hospital Clínic de Barcelona, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d’Unitats d’Expertesa Clínica (XUEC) for Autoinflammatory Diseases, Barcelona, Spain